Effects of beta-blocking agents on insulin secretion and glucose disposal.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Hormone and metabolic research. Supplement series

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 1975244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of beta-blocking drugs on glucose metabolism in patients with non-insulin dependent diabetes mellitus.

  2009cited by this paper
• Glucose tolerance and insulin release in hypertensive patients treated with the cardioselective beta-receptor blocking agent metoprolol.

  2009cited by this paper
• Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients

  2004cited by this paper
• Insulin resistance in essential hypertension.

  1987cited by this paper
• Abnormalities of carbohydrate and lipid metabolism in patients with hypertension.

  1987cited by this paper
• Evidence for an association of high blood pressure and hyperinsulinemia in obese man.

  1986cited by this paper
• Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion.

  1985cited by this paper
• Effects of beta-receptor blockade on carbohydrate metabolism.

  1985cited by this paper
• Effects of metoprolol and propranolol on glucose tolerance and insulin secretion in diabetes mellitus.

  1984cited by this paper
• Do antihypertensive drugs precipitate diabetes?

  1984cited by this paper
• Effect of the short-term beta-adrenoceptor blockade on exercise metabolism in cold weather.

  1984cited by this paper
• Metabolic consequences of antihypertensive therapy.

  1983cited by this paper
• Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus.

  1982cited by this paper
• beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects.

  1981cited by this paper
• Epinephrine-induced insulin resistance in man.

  1980cited by this paper
• Lack of effect of propranolol and metoprolol on glucose tolerance in maturity-onset diabetics.

  1980cited by this paper
• Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.

  1979cited by this paper
• Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.

  1979cited by this paper
• Adrenergic mechanisms in recovery from hypoglycemia in man: adrenergic blockade.

  1979cited by this paper
• The effects of atenolol and propranolol upon lipolysis.

  1978cited by this paper
• Propranolol-augmented, exercise-induced human growth hormone release.

  1975cited by this paper
• Adrenergic Modulation of Basal Insulin Secretion in Man

  1973cited by this paper
• Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.

  1971cited by this paper
• Lactate Turnover and Gluconeogenesis in Normal and Obese Humans: Effect of Starvation

  1970cited by this paper
• Liver and kidney metabolism during prolonged starvation.

  1969cited by this paper
• Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.

  1969cited by this paper
• [Asymptomatic diabetes mellitus in normal weight subjects with hypertension. Studies on glucose tolerance, serum insulin and nonesterified fatty acids in essential hypertension].

  1967cited by this paper
• Serum-insulin in essential hypertension and in peripheral vascular disease.

  1966cited by this paper

• Role of Systemic Factors in the Progression to Vision‐Threatening Diabetic Retinopathy in a New Mexican Patient Population with Type 2 Diabetes: Glycemic Control Is Not Enough

  2026cites this paper
• Terpenoids as potential phytoconstituent in the treatment of diabetes: From preclinical to clinical advancement.

  2024cites this paper
• Deciphering the involvement of norepinephrine and β-adrenergic receptor subtypes in glucose induced insulin secretion: an integrated in silico and in vitro exploration using isolated pancreatic islets of C57BL/6J mice

  2024cites this paper
• The Negative Impact of Insulin Resistance/Hyperinsulinemia on Chronic Heart Failure and the Potential Benefits of Its Screening and Treatment

  2023cites this paper
• DRUG INDUCED DIABETES

  2022cites this paper
• 12 Managing Hypertension in Patients with Diabetes

  2017cites this paper
• Clinically and pharmacologically relevant interactions of antidiabetic drugs

  2016cites this paper
• Increased low-grade inflammation is associated with lack of functional response to carvedilol in patients with systolic heart failure

  2013cites this paper
• Pharmacotherapy for the metabolic syndrome.

  2012cites this paper
• Drug-Induced Glucose Alterations Part 1: Drug-Induced Hypoglycemia

  2011cites this paper
• Choice of antihypertensive treatment in subjects with pre-diabetes. Is there a dream after the navigator.

  2011cites this paper
• Drug-Induced Glucose Alterations Part 2: Drug-Induced Hyperglycemia

  2011cites this paper
• Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension

  2011cites this paper
• Managing Hypertension in Patients with Diabetes

  2011cites this paper
• Secondary Causes of Diabetes Mellitus

  2010cites this paper
• [Not Available].

  2010cites this paper
• [Drug-induced hyperglycemia: a study in the French pharmacovigilance database].

  2010cites this paper
• Hypertensive Treatment in Patients With Metabolic Syndrome

  2010cites this paper
• som för avläggande av medicine doktorsexamen vid Karolinska Institutet offentligen försvaras i Thorax Aula, Karolinska Universitetssjukhuset i Solna, fredagen den 13 februari 2009 klockan 9.00 av

  2009cites this paper
• Perioperative Strokes and -Blockade

  2009cites this paper
• Permanent impairment of insulin resistance from pregnancy to adulthood: the primary basic risk factor of chronic Western diseases.

  2009cites this paper
• Acute myocardial infarction and glucose abnormalities : Novel risk markers and characteristics

  2009cites this paper
• Perioperative Strokes and &bgr;-Blockade

  2009cites this paper
• Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.

  2009cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2008cites this paper
• Modulation de la glycémie, de l'insuline et de la réponse hormonale contre-régulatrice à l'effort chez le diabétique de type 2 : influence du contenu en macronutriment d'un repas préalable, du statut nutritionnel et de la prise d'un bêtabloquant

  2007cites this paper
• Effects of Antihypertensives on Glucose Metabolism

  2007cites this paper
• Determinants of daily insulin use in Type 1 diabetes.

  2006cites this paper
• Cardioselective beta-blockers for chronic obstructive pulmonary disease.

  2005cites this paper
• Cardioselective beta-blockers for chronic obstructive pulmonary disease.

  2005cites this paper
• Antihypertensive drugs and incidence of type 2 diabetes: Evidence and implications for clinical practice

  2005cites this paper
• Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.

  2003cites this paper
• Cardioselective beta-blockers for chronic obstructive pulmonary disease : a meta-analysis

  2003cites this paper
• Cardioselective -Blockers in Patients with Reactive Airway Disease

  2002cites this paper
• Cardioselective (cid:1) -Blockers in Patients with Reactive Airway Disease: A Meta-Analysis

  2002cites this paper
• Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.

  2002cites this paper
• Cardioselective beta-blockers for reversible airway disease.

  2002cites this paper
• Drug-induced hyperglycemia.

  2001cites this paper
• Cardioselective beta-blocker use in patients with reversible airway disease.

  2001cites this paper
• Drug-Induced Disorders of Glucose Metabolism

  1996cites this paper
• Beta-blockers, dyslipidemia, and coronary artery disease. A reassessment.

  1993cites this paper
• Reducing the risk for coronary heart disease and stroke in hypertensives—comments on mechanisms for coronary protection and quality of life

  1992cites this paper